Results 11 to 20 of about 18,617,874 (263)

The effect of open-label placebo on anxiety, cortisol, and pain levels in children with procedural pain [PDF]

open access: yesFrontiers in Pediatrics
PurposeNeedle-related procedures are painful experiences for hospitalized children and are associated with anxiety, pain and stress. Open-label placebos (i.e., placebos administered honestly as an inert substance) have recently been shown to be as ...
Anna Lena Friedel   +8 more
doaj   +2 more sources

Open-label placebos as adjunctive therapy for patients with depression

open access: yesContemporary Clinical Trials Communications, 2022
Background: Placebos prescribed as ‘regular’ medication can reduce symptoms of depression. However, using a placebo without patients' informed consent presents ethical issues.
Anne Schienle, Nina Jurinec
doaj   +3 more sources

Effects of Open- and Closed-Label Nocebo and Placebo Suggestions on Itch and Itch Expectations [PDF]

open access: yesFrontiers in Psychiatry, 2019
Placebo and nocebo effects have been shown to influence subjective symptoms such as itch. These effects can be induced by influencing outcome expectations through, for example, combining the application of an inert substance (e.g., a cream) with verbal ...
Stefanie H. Meeuwis   +12 more
doaj   +2 more sources

Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects [PDF]

open access: yesScientific Reports, 2022
Placebos are known to yield significant effects in many conditions. We examined deceptive and open-label placebo effects on guilt, which is important for self-regulation and a symptom of mental disorders.
Dilan Sezer, Cosima Locher, Jens Gaab
doaj   +2 more sources

Effects of an open-label placebo intervention on reactions to social exclusion in healthy adults: a randomized controlled trial [PDF]

open access: yesScientific Reports, 2023
Social exclusion, that is being left out by others, can have adverse consequences for individuals’ psychological well-being. Even short-term experiences of social exclusion strongly threaten basic psychological needs and cause so-called social pain ...
Leonie Stumpp   +4 more
doaj   +2 more sources

Open label placebo to treat fatigue in people with multiple sclerosis: feasibility and preliminary effects [PDF]

open access: yesPilot and Feasibility Studies
Background Fatigue is highly prevalent in adults with multiple sclerosis (MS) and current treatments offer limited benefit. It has been speculated that placebos only have an effect when they are administered with deception and concealment, which is ...
Navneet Kaur Baidwan   +8 more
doaj   +2 more sources

A Fictionalist Account of Open-Label Placebo [PDF]

open access: yesThe Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine
Abstract The placebo effect is now generally defined widely as an individual’s response to the psychosocial context of a clinical treatment, as distinct from the treatment’s characteristic physiological effects. Some researchers, however, argue that such a wide definition leads to confusion and misleading implications.
Hardman, Doug
openaire   +3 more sources

Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial

open access: yesFrontiers in Medicine, 2021
Introduction: Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on ...
Dilan Sezer   +10 more
doaj   +3 more sources

A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis

open access: yesBMJ Open Gastroenterology, 2021
Objective Tumour necrosis factor signalling via the receptor-interacting protein kinase 1 (RIPK1) pathway regulates colonic inflammation suggesting that RIPK1 inhibition may be a potential therapeutic target in ulcerative colitis (UC).
Nicola Scott   +12 more
doaj   +2 more sources

Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial [PDF]

open access: yesEuropean Psychiatry, 2023
Introduction The response to placebo is robust in studies of various antidepressant treatments. The strong placebo response, combined with the absence of side-effects, has prompted suggestions to use the ethically sound open-label placebo (OLP) as a ...
U. Nitzan
doaj   +2 more sources

Home - About - Disclaimer - Privacy